tirzepatide generic date At a glance factsheet: for management of type 2 diabetes CHECK YOUR EXPIRATION DATES: A

With the launch of our oral semaglutide biosimilar, Obeda tablets, we are broadening our GLP1 portfolio to offer more choice and flexibility for patients

Hansoh Pharma will receive $112 million upfront and is eligible to receive up to $1.9 billion in milestone payments.

Teva Pharmaceuticals has launched the first generic GLP-1 drug for weight loss in adults and adolescents

In the Evaluate Renal Function With Semaglutide Once Weekly (FLOW) trial, semaglutide reduced the risk of major kidney and cardiovascular (CV) outcomes and all-cause mortality in people with type 2 diabetes (T2D) and chronic kidney disease (CKD)

Its FDA-approved for chronic weight management